I said "However, my understanding is the last chemo treatment...

First 26 Last

Share
Profile

Follow
Fire Bull

1,251 Posts.

19

12/03/19

21:27

Post #: 37738507
Share

Originally posted by Fire Bull: ↑

No worries, it is good to question the comparison as the mistake could easily have been mine. The study protocols can be quite intricate so it is easily done.

Agree that the path of improvement is key. However, my understanding is the last chemo treatment was day 56 so perhaps improvement we are seeing at what I think is day 98 is still the effect of chemo. I don't know if these timelines are correct for sure or if this scenario is likely.

In the Herceptin + chemo v chemo alone trial, median OS was 13.8 v 11.1 but as Axel Hoos explains in the below video, even median OS is not necessarily a good measure for evaluating immunotherapy as there may be a significant minority of patients who experience longterm benefit.

Whilst the response data we have looks like what we might expect if the treatment is working as desired, it really doesn't tell us much hence the lack of share price reaction. Now, if we get news every 84 days of continuing improvement in the data as the final patient progresses then it becomes increasingly likely that HER-vaxx works. Even no improvement in response rates but continued survival would be significant over time.

Do we know how many patients actually died to date?

First patient dosing was at the end of August in 2017 so that is more than 18 months ago. Are they still alive? How many HER-vaxx boosters has each patient had to date? Some of them could have had a few of these by now.

My understanding (although I'm not certain) is that the data we have is for all patients as at day 56 and again at day 98. If this is correct then except for the last patient, Imugene would know the status of patients beyond these periods and in some cases significantly beyond. So what has become of them? Have they continued to improve?

Expand

I said "However, my understanding is the last chemo treatment was day 56 so perhaps improvement we are seeing at what I think is day 98 is still the effect of chemo."

On rereading the study design I think chemo could continue after day 56.

IMU Price at posting: 2.0¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

CXM

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 18 more messages in this thread...

First 26 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 3.8¢		Change 0.000(0.00%)		Mkt cap ! $386.7M

Open	High	Low	Value	Volume
3.8¢	3.8¢	3.7¢	$270.7K	7.251M

Buyers (Bids)

No.	Vol.	Price($)
11	949810	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	2277658	11

View Market Depth

No.	Vol.	Price($)
18	5665336	0.018
14	3997559	0.017
6	2974375	0.016
10	3219799	0.015
4	497500	0.014

Price($)	Vol.	No.
0.019	400000	2
0.020	5410946	12
0.021	8494780	17
0.022	8757253	13
0.023	4826614	8

Last trade - 16.10pm 26/11/2024 (20 minute delay)

IMU (ASX) Chart

I said "However, my understanding is the last chemo treatment...

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Buyers (Bids)

Sellers (Offers)